Guardant Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Guardant Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Guardant Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $604M, a 23.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $604M +$115M +23.5% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $489M +$176M +56.2% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $313M +$189M +152% Dec 31, 2021 10-K 2023-02-23
Q4 2020 $124M -$812K -0.65% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $125M +$59M +89.2% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $66.2M +$22.5M +51.5% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $43.7M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.